Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma
5 المشاهدات
• 08/09/23
0
0
تضمين
administrator
مشتركين
Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, discusses the scenarios in which she has seen the most benefit from brentuximab vedotin (Adcetris) in patients with advanced stage cutaneous T-cell lymphoma (CTCL).
أظهر المزيد
تعليقات الفيسبوك
SORT BY-
أعلى تعليقات
-
أحدث تعليقات